$AYTU Thus far, it has been extremely difficult for antibody tests using the lateral flow assay to get an EUA. The lateral flow tests are the ones that have been labeled "faulty" by many doctors and scientists due to their unreliability in detecting COVID-19. Getting an EUA for a lateral flow antibody test is a huge deal since there are so many unreliable ones on the market. Only three lateral flow antibody tests have been given an EUA so far: Cellex, Chembio, and Autobio. (Cardinal Health distributes two of these with Aytu's test being another). If Orient Gene/Biolidics get an EUA, Aytu will own the exclusive U.S. distribution rights for 2/5 EUA lateral flow antibody tests.